Mr. Harry Werner Kirsch is a Chief Financial Officer at Novartis AG.
He is on the Board of Directors at Novartis Institutes for Biomedical Research, Inc., Novartis Vaccines & Diagnostics, Inc., Novartis International AG, Novartis Pharma AG and Novartis Pharma KK. Mr. Kirsch was previously employed as a CFO-Global Pharmaceutical Business by Procter & Gamble Co.
He also served on the board at GlaxoSmithKline Consumer Healthcare Pte Ltd.
He received his undergraduate degree from Karlsruher Institut für Technologie.